Companies Dominating the Benzyl Salicylate Landscape
- Zhenjiang Gaopeng Pharmaceutical CO,.Ltd
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Jiangsu Puyuan Chemical Co.,Ltd
- JQC (Huayin) Pharmaceuticals Co., Ltd.
- ECSA Chemicals AG
- LLUCH ESSENCE S.A de C.V.
- OQEMA AG.
- Glentham Life Sciences Limited.
- Taytonn ASCC Pte Ltd
- WholeChem, LLC.
- The Lermond Company, LLC
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of benzyl salicylate is assessed at USD 85.67 million.
The benzyl salicylate market size was valued at USD 82.6 million in 2024 and is likely to cross USD 111.01 million by 2037, registering more than 2.3% CAGR during the forecast period i.e., between 2025-2037. Increasing expenditure on personal beauty and cosmetic products along with rising adoption of sunscreens and rise in disposable income will boost the market growth.
North America industry is expected to account for largest revenue share by 2037, attributed to rising demand for personal care products and increased awareness about the therapeutic benefits of salicylate-based products.
The major players in the market are Zhenjiang Gaopeng Pharmaceutical CO,.Ltd, Jiangsu Puyuan Chemical Co., Ltd, JQC (Huayin) Pharmaceuticals Co., Ltd., ECSA Chemicals AG, LLUCH ESSENCE S.A de C.V., OQEMA AG., Glentham Life Sciences Limited., Taytonn ASCC Pte Ltd, WholeChem, LLC., The Lermond Company, LLC
